Ser358
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.5
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser358  -  GRB14 (human)

Site Information
MHPYQGRsGCSsQSI   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 31834913

In vivo Characterization
Methods used to characterize site in vivo:
immunoprecipitation ( 1 ) , mass spectrometry ( 2 ) , mass spectrometry (in vitro) ( 1 ) , microscopy-colocalization with upstream kinase ( 2 ) , mutation of modification site ( 1 , 2 )
Disease tissue studied:
liver cancer ( 2 )
Relevant cell line - cell type - tissue:
COS7 (fibroblast) ( 1 , 2 ) , S.cerevisiae ( 1 )

Upstream Regulation
Putative in vivo kinases:
GSK3A (human) ( 1 ) , GSK3B (human) ( 2 )
Kinases, in vitro:
CK2A1 (human) ( 2 ) , GSK3A (human) ( 1 ) , GSK3B (human) ( 1 , 2 )

Downstream Regulation
Effects of modification on GRB14:
molecular association, regulation ( 1 , 2 ) , phosphorylation ( 2 )
Inhibit interaction with:
INSR (human) ( 1 , 2 )

References 

1

Taira J, et al. (2017) Phosphorylation of clustered serine residues in the N-terminus of BPS domain negatively regulates formation of the complex between human Grb14 and insulin receptor. J Biochem 162, 113-122
28130417   Curated Info

2

Taira J, Higashimoto Y (2014) Phosphorylation of Grb14 BPS domain by GSK-3 correlates with complex forming of Grb14 and insulin receptor. J Biochem 155, 353-60
24535599   Curated Info

Developed with grants from  NIH Logo and literature mining with Linguamatics  I2E Logo Creative Commons License PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.

©2003-2024 Cell Signaling Technology, Inc.